These data, consistent with previous studies 3-10, indicated that iASPP, as a newly identified oncoprotein, was involved in the carcinogenesis and progression of early stage cervical cancer and might serve as novel potential therapeutic target. Here, PPP1R13L is linked to cervical carcinoma.